Ranbaxy

Case History In an attempt to protect Lipitor from generic competition, Pfizer sued Ranbaxy in district court asserting, in part, that Ranbaxy infringed upon dependent Claim 6 of U.S. Patent No. 5,273,995 ( 995). 

Artemisinin (8) doperoxide sesquiterpene lactone Arterolane (RBX11160, OZ-277) (64) Antiparasitic (antimalarial) Under study (on interation of peroxide moiety with parasite targets) Phase III Ranbaxy 561-565... 

Ranbaxy Press release 4 May 2009. Available at http //www.ranbaxy.com/. 

Cir. 2001) Glaxo Group, Ltd v. Ranbaxy Pharms., Inc., 262 F.3d 1333, 1338 (Fed. Cir. 2001) (discussing district court s decision to grant preliminary injunction because generic manufacturer could not pay NDA holder s potential damages) see Chisum on Patents, 20.04(e)(iv) (Matthew Bender). 

Liquid anhydrous morphine equiv. to 10 mg per mL (c-//) Opium Tincture, Deodorized Ranbaxy)... 

Medium pharma 50-100 Sales 0.5- 5 billion, regional reach, <300 m reactor volume, limited R D capabilities, mainly unlicensed drugs and generics. Barr, Forest, Sepracor, USA Altana, Merck, Stada, Germany Sankyo, Japan Dr Reddy s, Ranbaxy, India... 

An example is the AstraZenecas anticholesterol drug Crestor (rosuvastatin). Although the patent expires only in 2012, there are already about 25 manufacturers in India, including famous names such as Ranbaxy (Rosuvas) and Dr Reddy s Laboratories (Rosvat). 

Ranbaxy Laboratories Ltd. Allan (SpA, Italy) (gsk s Italian generics business) Generics N/A... 

Ranbaxy alleged that because the compound of claim 2 was specifically described only as the carboxylic acid, it did not allow for the possibility of a hemicalcium salt meaning that the compound of claim 6 could not be the salt either claim 6 depends on claim 2 and, therefore, cannot expand the definition of claim 2.52 The CAFC agreed... 

---